81
Participants
Start Date
November 17, 2020
Primary Completion Date
May 17, 2023
Study Completion Date
May 17, 2023
PAPILOCARE
"Papilocare® is a self-administered vaginal gel. Its single-dose cannula contains hyaluronic acid and pre-biotics (Coriolus Versicolor) that would improve the re-epithelialization of the uterin cervix. By creating a protective film on the cervix, this gel could induce a favorable environment for regression of the cervical intraepithelial lesions 1 and for clearance of Human Papillomavirus.~The specific approach related to our study would be to apply Papilocare® vaginal gel for 6 months for the treated group.~Smear and HPV test will be perform by all patients at 6 and 12 months."
Centre Hospitalier Régional d'Orléans, France, Orléans
Centre Hospitalier Régional d'Orléans
OTHER